The global companion animal specialty drugs market is poised for steady growth, with projections indicating a moderate-paced Compound Annual Growth Rate (CAGR) of 4.21% over the forecast period. The market, which was valued at USD 37,624.67 million in 2022, is anticipated to reach an impressive USD 56,828.56 million by 2032. This growth trajectory reflects a …